Hester Biosciences (BOM:524669) OCF Yield %: 3.10 (As of Jul. 18, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524669 Hester Biosciences Ltd BOM:524669
72 GF Score
Price ₹2,445.15
GF Value ₹1,891.98
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Hester Biosciences OCF Yield %?

Hester Biosciences BOM:524669 +0.37% 72 OCF Yield % is 3.10 as of Jul. 18, 2026. GuruFocus rates BOM:524669 with a GF Score™ of 72/100 and a GF Value™ of ₹1,891.98 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 1,007 Drug Manufacturers companies, Hester Biosciences ranks worse than 52.04% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Hester Biosciences's Trailing 12-Month Cash Flow from Operations is ₹0 Mil, and Market Cap is ₹20,801 Mil. Therefore, Hester Biosciences's OCF Yield % for today is 3.10%.

The historical rank and industry rank for Hester Biosciences's OCF Yield % or its related term are showing as below:

BOM:524669' s OCF Yield % Range Over the Past 10 Years
Min: 3.1   Med: 0   Max: 3.1
Current: 3.1


During the past 13 years, the highest OCF Yield % of Hester Biosciences was 3.10%. The lowest was 3.10%. And the median was %.

BOM:524669's OCF Yield % is ranked worse than
52.04% of 1007 companies
in the Drug Manufacturers industry
Industry Median: 3.55 vs BOM:524669: 3.10

Hester Biosciences's OCF Margin % for the quarter that ended in Mar. 2026 was %.


Hester Biosciences OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Hester Biosciences OCF Yield % Related Terms


Hester Biosciences OCF Yield % Historical Data

* Premium members only.

The historical data trend for Hester Biosciences's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hester Biosciences OCF Yield % Chart

Hester Biosciences Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
OCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.38 1.82 4.08 6.05 5.97

Hester Biosciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BOM:524669 vs ZTS, UTHR: OCF Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Hester Biosciences's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hester Biosciences OCF Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hester Biosciences's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Hester Biosciences's OCF Yield % falls into.


BOM:524669
72GF Score
Hester Biosciences Ltd BOM:524669
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hester Biosciences OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Hester Biosciences's OCF Yield % for the fiscal year that ended in Mar. 2026 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=641.41 / 10741.36355
=5.97%

Hester Biosciences's annualized OCF Yield % for the quarter that ended in Mar. 2026 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=0 * 4 / 10741.36355
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of 3.10 mean?
Hester Biosciences (BOM:524669) has a OCF Yield % of 3.10 as of Jul. 18, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Hester Biosciences and its competitors. Over the past decade, Hester Biosciences' OCF Yield % has ranged from 3.10 to 3.10. According to the industry distribution chart, Hester Biosciences ranks #524 out of 1007 companies in the Drug Manufacturers industry, placing it in the top 52%.
Is Hester Biosciences' OCF Yield % too high?
Hester Biosciences' current OCF Yield % is 3.10. Over the past 10 years, this metric has ranged from a low of 3.10 to a high of 3.10. The Drug Manufacturers industry median OCF Yield % is 3.55. Hester Biosciences' value of 3.10 is 12.7% below this industry median. Based on the distribution chart, Hester Biosciences ranks #524 out of 1007 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Hester Biosciences has a GF Score™ of 72/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hester Biosciences' OCF Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Hester Biosciences ranks #524 out of 1007 companies for OCF Yield %. This places Hester Biosciences in the lower half of its industry. The industry median OCF Yield % is 3.55. Hester Biosciences' value of 3.10 is 12.7% below this benchmark. Historically, Hester Biosciences' own OCF Yield % has ranged from 3.10 to 3.10 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.55, based on 1,007 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hester Biosciences's current OCF Yield % of 3.10 is 12.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Hester Biosciences and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hester Biosciences's current OCF Yield % is 3.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hester Biosciences stock overvalued right now?
Based on GuruFocus' analysis, Hester Biosciences (BOM:524669) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹1,891.98, compared to a current price of ₹2,445.15 — trading 29.2% above its estimated fair value. The current OCF Yield % is 3.10 and 12.7% below the Drug Manufacturers industry median of 3.55. Hester Biosciences' overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Hester Biosciences (BOM:524669), the current OCF Yield % is 3.10 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hester Biosciences (BOM:524669) Overvalued in 2026?

Based on GuruFocus' analysis, Hester Biosciences stock appears to be overvalued. The current stock price of ₹2,445.15 is trading 29.2% above its estimated GF Value™ of ₹1,891.98. GuruFocus considers Hester Biosciences to be Modestly Overvalued.

Key valuation signals for BOM:524669:

  • OCF Yield %: 3.10
  • GF Value™: ₹1,891.98 vs. price of ₹2,445.15 (29.2% above fair value)
  • GF Score™: 72/100 with 5 warning signs
  • Industry Position: 12.7% below the Drug Manufacturers median (#524 of 1007)

No single metric tells the full story. See the BOM:524669 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Hester Biosciences Business Description

Other Exchanges HESTERBIO:India
Address Village Meda - Adraj, Taluka Kadi, District Mehsana, Mehsana, GJ, IND, 384441
Hester Biosciences Ltd is an India-based animal healthcare company. It is principally engaged in the manufacturing of veterinary vaccines and trading of veterinary health products such as goat pox vaccine, PPR vaccines, etc. The group has two principal operating and reporting segments, viz. Poultry healthcare and Animal healthcare. Maximum revenue is generated from the Poultry Healthcare segment, which offers various solutions encompassing vaccines, health products, and feed supplements, supported and packaged by its diagnostic services, R&D, quality standards, and field support, to help farmers protect flock health, enhance productivity, and drive long-term farm sustainability. Geographically, it generates maximum revenue within India, and also exports its products to other markets.
72GF Score

Get the complete analysis for BOM:524669

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹2,445.15
Price
₹1,891.98
GF Value